Doravirine; Islatravir Patent Expiration
Doravirine; Islatravir was first introduced by Merck Sharp And Dohme Llc
Doravirine; Islatravir Patents
Given below is the list of patents protecting Doravirine; Islatravir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Idvynso | US8486975 | Non-nucleoside reverse transcriptase inhibitors | Aug 30, 2032 | Msd |
| Idvynso | US7339053 | 4'-C-Substituted-2-Haloadenosine Derivative | May 31, 2027 | Msd |
Doravirine; Islatravir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List